Follow The Filings

CSTL Castle Biosciences

Castle Biosciences earnings company data as of 4:45 AM ET 11/6

  • 1 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS -0.35 -0.13 Beat
Rev $92.5M $102.9M Beat +11.2%

Insider trades

Open-market buys and sales by CSTL's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CSTL insider trades
  • None no insider bought on the open market
  • $3M sold by 4 insiders outside a trading plan
  • $16.7M sold by 4 insiders under 10b5-1 plans
  1. Derek J Maetzold Pres. & Chief Exec. Officer
    Planned sale
    $523K 14,496 shares at $36.10
    Traded Nov 2 Filed Nov 4
  2. Tobin W Juvenal Chief Commercial Officer
    Planned sale
    $240K 6,578 shares at $36.42 15% of stake
    Traded Oct 28 Filed Oct 30
  3. Tobin W Juvenal Chief Commercial Officer
    Planned sale
    $109K 3,288 shares at $33.08 6.7% of stake
    Traded Oct 26 Filed Oct 28
  4. Derek J Maetzold Pres. & Chief Exec. Officer
    Planned sale
    $463K 14,496 shares at $31.91
    Traded Oct 19 Filed Oct 21
  5. Tobin W Juvenal Chief Commercial Officer
    Planned sale
    $111K 3,288 shares at $33.64 6.3% of stake
    Traded Oct 12 Filed Oct 14
  6. Derek J Maetzold Pres. & Chief Exec. Officer
    Planned sale
    $516K 14,496 shares at $35.57
    Traded Oct 5 Filed Oct 7
  7. Kristen M Oelschlager COO
    Planned sale
    $149K 4,153 shares at $35.95 24% of stake
    Traded Oct 1 Filed Oct 5
  8. Tobin W Juvenal Chief Commercial Officer
    Planned sale
    $232K 6,577 shares at $35.29 11% of stake
    Traded Sep 29–30 Filed Oct 1
  9. Derek J Maetzold Pres. & Chief Exec. Officer
    Planned sale
    $512K 14,496 shares at $35.33
    Traded Sep 21 Filed Sep 23
  10. Tobin W Juvenal Chief Commercial Officer
    Planned sale
    $223K 6,600 shares at $33.73 10% of stake
    Traded Sep 14–15 Filed Sep 16
  11. Derek J Maetzold Pres. & Chief Exec. Officer
    Planned sale
    $465K 14,518 shares at $32.02
    Traded Sep 11 Filed Sep 15
  12. Kristen M Oelschlager COO
    Planned sale
    $139K 4,152 shares at $33.39 24% of stake
    Traded Sep 1 Filed Sep 3
  13. Tobin W Juvenal Chief Commercial Officer
    Planned sale
    $57K 1,730 shares at $32.81 2.6% of stake
    Traded Aug 31 Filed Sep 2
  14. Derek J Maetzold Pres. & Chief Exec. Officer
    Planned sale
    $616K 18,560 shares at $33.20
    Traded Aug 28 Filed Sep 1
  15. Tobin W Juvenal Chief Commercial Officer
    Planned sale
    $317K 9,050 shares at $35.04 12% of stake
    Traded Aug 25 Filed Aug 27

Also filed in the last 12 months, not counted as buying or selling: 50 option exercises, 16 share withholdings for taxes, and 4 stock grants.

SEC filings

Recent issuer filings from EDGAR, 5 shown.

Filed Form Detail Links
10-Q
8-K 2.02,7.01,9.01
SCHEDULE 13G/A —
8-K 2.02,7.01,9.01
10-Q

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf